PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 8.715
EU - Europa 4.024
AS - Asia 1.884
SA - Sud America 99
AF - Africa 16
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.753
Nazione #
US - Stati Uniti d'America 8.596
IT - Italia 893
CN - Cina 715
DE - Germania 690
SG - Singapore 644
IE - Irlanda 511
SE - Svezia 504
RU - Federazione Russa 406
UA - Ucraina 294
HK - Hong Kong 241
AT - Austria 189
GB - Regno Unito 174
FR - Francia 108
CA - Canada 106
FI - Finlandia 83
BR - Brasile 73
VN - Vietnam 71
DK - Danimarca 63
IN - India 51
TR - Turchia 44
ID - Indonesia 43
NL - Olanda 39
JP - Giappone 33
ES - Italia 21
BE - Belgio 15
CH - Svizzera 8
MX - Messico 8
AU - Australia 7
IR - Iran 7
SA - Arabia Saudita 7
CO - Colombia 6
PE - Perù 6
CZ - Repubblica Ceca 5
EU - Europa 5
IL - Israele 5
KR - Corea 5
AR - Argentina 4
CL - Cile 4
EC - Ecuador 4
EG - Egitto 4
PL - Polonia 4
GR - Grecia 3
LT - Lituania 3
PA - Panama 3
RO - Romania 3
SC - Seychelles 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
BT - Bhutan 1
ET - Etiopia 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 14.753
Città #
Ann Arbor 2.328
Woodbridge 670
Fairfield 669
Chandler 562
Singapore 507
Dublin 494
Houston 475
Wilmington 463
Ashburn 448
Frankfurt am Main 445
Jacksonville 297
Seattle 294
Dearborn 261
Hong Kong 239
New York 231
Cambridge 222
Milan 198
Princeton 194
Vienna 182
Santa Clara 162
Nanjing 141
Lawrence 92
Altamura 91
Beijing 78
Shanghai 62
San Diego 53
Dong Ket 48
Jakarta 43
Lachine 43
Nanchang 42
Guangzhou 40
Falls Church 37
Boardman 32
Lissone 32
Andover 31
Jinan 30
Shenyang 30
Helsinki 29
London 28
Tianjin 27
Rome 25
Ottawa 24
Pune 24
Changsha 20
Hebei 20
Zhengzhou 19
Ningbo 18
Kunming 16
Norwalk 16
Toronto 16
Brussels 15
Fremont 15
Hangzhou 15
Jiaxing 15
Nuremberg 15
Monza 14
Huizen 13
Redmond 13
Edmonton 12
Kocaeli 12
Los Angeles 12
Auburn Hills 11
Dallas 10
São Paulo 10
Kiev 9
Mountain View 8
Munich 8
Naples 8
Nürnberg 8
San Mateo 8
Taizhou 8
Washington 8
Hefei 7
Leawood 7
Paullo 7
Turin 7
Detroit 6
Duncan 6
Genoa 6
Kilburn 6
Madrid 6
Montréal 6
Saint Louis 6
Taiyuan 6
Tokyo 6
Xiamen 6
Bari 5
Belo Horizonte 5
Brno 5
Chicago 5
Cinisello Balsamo 5
Ho Chi Minh City 5
Jerusalem 5
Pavia 5
Pescara 5
Salerno 5
Shenzhen 5
University Park 5
Wuhan 5
Abbiategrasso 4
Totale 10.952
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 357
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 349
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 346
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 309
MALDI imaging in Fabry nephropathy: a multicenter study 302
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 271
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 266
Microscopic Polyangiitis 262
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 248
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 246
Kidney Involvement 241
The putative role of MALDI-MSI in the study of Membranous Nephropathy 235
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 234
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 233
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 228
Proteomics for the study of new biomarkers in Fabry disease: State of the art 208
Usefulness of waist circumference for the identification of childhood hypertension 207
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 206
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 198
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 196
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 191
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 190
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 184
Obesity-associated hypertension in childhood: A new epidemic problem 181
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 177
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 176
Parapelvic cysts, a distinguishing feature of renal Fabry disease 173
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 172
Role of fat distribution indicators in the identification of hypertension in children 170
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 170
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 169
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 169
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 165
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 165
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 161
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 161
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 159
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 155
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 154
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 150
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 150
Renal afferents signaling diuretic activity in the cat 149
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 149
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 147
Sympathetic activation in cardiovascular and renal disease 145
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 143
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 141
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 139
ANCA-associated vasculitis in childhood: Recent advances 139
Anticoagulant-related nephropathy: a pathological note 139
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 138
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 137
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 136
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 134
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 126
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 126
Hypertension in childhood: autonomic and metabolic patterns 125
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 125
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 124
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 123
Redefining the pulvinar sign in fabry disease 122
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 119
Avacopan for the treatment of ANCA-associated vasculitis 119
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 119
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 118
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 117
Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment 116
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 116
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 114
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 109
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 109
[Clinical and histological findings in Fabry nephropathy] 107
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 107
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 106
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 103
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 103
Tumour incidence in Fabry disease: A cross-sectional study 102
La terapia enzimatica sostitutiva nella malattia di Fabry 102
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 101
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 100
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 98
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 97
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 94
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 90
La diagnosi precoce di malattia 87
SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience 82
Cardiological follow-up in patients with Fabry disease 78
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 77
Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management [Il coinvolgimento cardiaco nella malattia di Anderson-Fabry: Nuove raccomandazioni sulla diagnosi, il follow-up e la terapia] 76
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 76
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 74
Atrial Dysfunction Assessed by Cardiac Magnetic Resonance as an Early Marker of Fabry Cardiomyopathy 69
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 69
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 62
Renal reflexes and denervation in heart failure 62
The GALA project: Practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts 56
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 55
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 52
Interpretation of GFR slope in untreated and treated adult Fabry patients 49
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 46
Totale 14.927
Categoria #
all - tutte 54.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020970 0 0 0 0 0 0 303 162 205 114 147 39
2020/20212.474 126 79 210 228 211 251 278 308 218 215 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20251.870 266 395 261 189 345 148 266 0 0 0 0 0
Totale 15.324